These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36738564)

  • 1. Chemical language models for de novo drug design: Challenges and opportunities.
    Grisoni F
    Curr Opin Struct Biol; 2023 Apr; 79():102527. PubMed ID: 36738564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances and Challenges in De Novo Drug Design Using Three-Dimensional Deep Generative Models.
    Xie W; Wang F; Li Y; Lai L; Pei J
    J Chem Inf Model; 2022 May; 62(10):2269-2279. PubMed ID: 35544331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular design in drug discovery: a comprehensive review of deep generative models.
    Cheng Y; Gong Y; Liu Y; Song B; Zou Q
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34415297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep learning for molecular generation.
    Xu Y; Lin K; Wang S; Wang L; Cai C; Song C; Lai L; Pei J
    Future Med Chem; 2019 Mar; 11(6):567-597. PubMed ID: 30698019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive assessment of deep generative architectures for de novo drug design.
    Wang M; Sun H; Wang J; Pang J; Chai X; Xu L; Li H; Cao D; Hou T
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34929743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep Generative Models in
    Pang C; Qiao J; Zeng X; Zou Q; Wei L
    J Chem Inf Model; 2024 Apr; 64(7):2174-2194. PubMed ID: 37934070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graph-based generative models for de Novo drug design.
    Xia X; Hu J; Wang Y; Zhang L; Liu Z
    Drug Discov Today Technol; 2019 Dec; 32-33():45-53. PubMed ID: 33386094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MolGPT: Molecular Generation Using a Transformer-Decoder Model.
    Bagal V; Aggarwal R; Vinod PK; Priyakumar UD
    J Chem Inf Model; 2022 May; 62(9):2064-2076. PubMed ID: 34694798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNMG: Deep molecular generative model by fusion of 3D information for de novo drug design.
    Song T; Ren Y; Wang S; Han P; Wang L; Li X; Rodriguez-Patón A
    Methods; 2023 Mar; 211():10-22. PubMed ID: 36764588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generative artificial intelligence in drug discovery: basic framework, recent advances, challenges, and opportunities.
    Gangwal A; Ansari A; Ahmad I; Azad AK; Kumarasamy V; Subramaniyan V; Wong LS
    Front Pharmacol; 2024; 15():1331062. PubMed ID: 38384298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generative Deep Learning for Targeted Compound Design.
    Sousa T; Correia J; Pereira V; Rocha M
    J Chem Inf Model; 2021 Nov; 61(11):5343-5361. PubMed ID: 34699719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generative machine learning for de novo drug discovery: A systematic review.
    Martinelli DD
    Comput Biol Med; 2022 Jun; 145():105403. PubMed ID: 35339849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo drug design as GPT language modeling: large chemistry models with supervised and reinforcement learning.
    Ye G
    J Comput Aided Mol Des; 2024 Apr; 38(1):20. PubMed ID: 38647700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Status and Prospects of Research on Deep Learning-based De Novo Generation of Drug Molecules.
    Shi H; Wang Z; Zhou L; Xu Z; Xie L; Kong R; Chang S
    Curr Comput Aided Drug Des; 2024 Feb; ():. PubMed ID: 38321907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo molecular design and generative models.
    Meyers J; Fabian B; Brown N
    Drug Discov Today; 2021 Nov; 26(11):2707-2715. PubMed ID: 34082136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep Learning Applied to Ligand-Based De Novo Drug Design.
    Palazzesi F; Pozzan A
    Methods Mol Biol; 2022; 2390():273-299. PubMed ID: 34731474
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Grisoni F; Schneider G
    Chimia (Aarau); 2019 Dec; 73(12):1006-1011. PubMed ID: 31883552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo molecular design with deep molecular generative models for PPI inhibitors.
    Wang J; Chu Y; Mao J; Jeon HN; Jin H; Zeb A; Jang Y; Cho KH; Song T; No KT
    Brief Bioinform; 2022 Jul; 23(4):. PubMed ID: 35830870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Training recurrent neural networks as generative neural networks for molecular structures: how does it impact drug discovery?
    D'Souza S; Kv P; Balaji S
    Expert Opin Drug Discov; 2022 Oct; 17(10):1071-1079. PubMed ID: 36216812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo generation of dual-target ligands using adversarial training and reinforcement learning.
    Lu F; Li M; Min X; Li C; Zeng X
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34410338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.